A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. [electronic resource]
Producer: 20100727Description: 1333-7 p. digitalISSN:- 1468-2060
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- diagnostic imaging
- Autoantibodies -- blood
- C-Reactive Protein -- metabolism
- Disease Progression
- Drug Therapy, Combination
- Epidemiologic Methods
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Infliximab
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Peptides, Cyclic -- immunology
- Prednisone -- therapeutic use
- Radiography
- Rheumatoid Factor -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.